Document ID: chunk:federal_register_of_legislation:F2024C00525:front:0:p3
Version: federal_register_of_legislation:F2024C00525
Segment Type: other
Provision Reference: 
Character Range: 5954–8777

in a manufacture licence—persons prescribed
38 Application for manufacture permit—information requirements
Division 2—Conditions of manufacture licences
39 Condition that manufacture licence holder employ or engage suitable staff
40 Condition that manufacture licence holder notify the Secretary of certain matters
Division 3—Variation, suspension and surrender of manufacture licences and manufacture permits
Subdivision A—Variation of manufacture licences and permits
41 Circumstances in which a manufacture licence or manufacture permit must not be varied
42 Application for variation of manufacture licence or permit—information requirements
43 Application for variation of manufacture licence or permit—document requirements
Subdivision B—Suspension of manufacture licences and permits
44 Suspension of manufacture licences and permits
45 Secretary may suspend manufacture licences and permits
46 Secretary to notify of proposed suspension of manufacture licence or permit
47 Effect of suspension of manufacture licences
47A Effect of suspension of manufacture permit
48 Revocation of suspension of manufacture licence or permit
49 Matters not affected by suspension of manufacture licence or permit
Subdivision C—Surrender of manufacture licences and permits
50 Surrender of manufacture licences and permits
51 Licence holder may surrender manufacture licence or permit
Part 4—Review of decisions
52 Reviewable decisions
Part 5—Other matters
Division 1—Inspection fees
54 Inspection fees
Division 1A—Charges
54A Classes of medicinal cannabis licences for the purposes of charge
54B Payment of charge
54C Recovery of charge
Division 2—Other matters
55 Secretary to notify States and Territories of certain matters
56 Modification of operation of Chapters 2 and 3 of the Act
Part 6—Application, saving and transitional provisions
57 Application provisions relating to the Narcotic Drugs Amendment (Cannabis) Regulations 2018
58 Application provisions relating to the Narcotic Drugs Amendment (Review Recommendations) Regulations 2019
59 Application provisions relating to the Narcotic Drugs Amendment (Fees) Regulations 2020
60 Application provisions relating to the Narcotic Drugs Amendment (Cannabis‑Related Manufacture Licences and Permits) Regulations 2020
61 Application provisions relating to the Narcotic Drugs Amendment (Fees) Regulations 2021
62 Application provisions relating to the Narcotic Drugs Amendment (Medicinal Cannabis) Regulations 2021
63 Application of amendments of the Narcotic Drugs Amendment (Fees) Regulations 2023
64 Application provisions relating to the Narcotic Drugs Amendment (Fees) Regulations 2024
Schedule 1—Application fees
1 Table of fees
Endnotes
Endnote 1—About the endnotes
Endnote 2—Abbreviation key
Endnote 3—Legislation history
Endnote 4—Amendment history

Part 1—Preliminary